(Q34566408)

3 August 2017

1 reference

title

Pharmacologic and genetic therapy for childhood muscular dystrophies (English)

1 reference

3 August 2017

Escolar DM

1

1 reference

3 August 2017

Scacheri CG

series ordinal

2

1 reference

3 August 2017

publication date

1 March 2001

1 reference

Current Neurology and Neuroscience Reports

3 August 2017

published in

1 reference

3 August 2017

volume

1

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

168-174

1 reference

Activation of utrophin promoter by heregulin via the ets-related transcription factor complex GA-binding protein alpha/beta

3 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11910-001-0013-Y

Cyclosporine increases muscular force generation in Duchenne muscular dystrophy.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11910-001-0013-Y

A beneficial effect of oxandrolone in the treatment of Duchenne muscular dystrophy: a pilot study.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11910-001-0013-Y

Muscle and neural isoforms of agrin increase utrophin expression in cultured myotubes via a transcriptional regulatory mechanism

21 January 2018

1 reference

12 December 2020

The effects of knee-ankle-foot orthoses in the treatment of Duchenne muscular dystrophy: review of the literature

1 reference

12 December 2020

Respiratory muscle training in neuromuscular disease: long-term effects on strength and load perception.

1 reference

12 December 2020

Full functional rescue of a complete muscle (TA) in dystrophic hamsters by adeno-associated virus vector-directed gene therapy

1 reference

12 December 2020

Clinical investigation in duchenne dystrophy: 2. Determination of the ?power? of therapeutic trials based on the natural history

1 reference

12 December 2020

Steroids in duchenne muscular dystrophy — Deflazacort trial

1 reference

12 December 2020

Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals

1 reference

12 December 2020

Homozygous alpha-sarcoglycan mutation in two siblings: one asymptomatic and one steroid-responsive mild limb-girdle muscular dystrophy patient

1 reference

12 December 2020

Long-term benefit from prednisone therapy in Duchenne muscular dystrophy

1 reference

12 December 2020

Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophy

1 reference

12 December 2020

Deflazacort in Duchenne dystrophy: study of long-term effect

1 reference

12 December 2020

Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles

1 reference

12 December 2020

Conservation of the Duchenne muscular dystrophy gene in mice and humans

1 reference

12 December 2020

Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy.

1 reference

12 December 2020

Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy

1 reference

12 December 2020

Pre-clinical screening of drugs using the mdx mouse

1 reference

12 December 2020

Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice

1 reference

12 December 2020

Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse

1 reference

12 December 2020

Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study

1 reference

12 December 2020

Phase I clinical trial utilizing gene therapy for limb girdle muscular dystrophy: alpha-, beta-, gamma-, or delta-sarcoglycan gene delivered with intramuscular instillations of adeno-associated vectors

1 reference

12 December 2020

Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles.

1 reference

12 December 2020

Oral glutamine slows down whole body protein breakdown in Duchenne muscular dystrophy

1 reference

12 December 2020

Duchenne muscular dystrophy

1 reference

12 December 2020

A role for mast cells in the progression of Duchenne muscular dystrophy? Correlations in dystrophin-deficient humans, dogs, and mice

1 reference

12 December 2020

Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months)

1 reference

12 December 2020

Pulmonary manifestations of neuromuscular disease with special reference to Duchenne muscular dystrophy and spinal muscular atrophy

1 reference

12 December 2020

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

1 reference

12 December 2020

A multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy

1 reference

12 December 2020

Primary alpha-sarcoglycan deficiency responsive to immunosuppression over three years

1 reference

12 December 2020

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy

1 reference

12 December 2020

10.1007/S11910-001-0013-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1033121545

0 references

1 reference